Pharmaceutical formulations of antineoplastic agents and...

Details Pharmaceutical formulations of antineoplastic agents and... Pharmaceutical formulations of antineoplastic agents and...

2006-01-17

2006-01-17

Weddington, Kevin E. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S396000, C514S613000

Reexamination Certificate

active

06987108

ABSTRACT:
In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof.

REFERENCES:
patent: 4455256 (1984-06-01), Urist
patent: 4675183 (1987-06-01), Kato et al.
patent: 5227373 (1993-07-01), Alexander et al.
patent: 5731304 (1998-03-01), Baer et al.
patent: 6251886 (2001-06-01), Friedman
patent: 6803365 (2004-10-01), Niewohner et al.
patent: 0653210 (1995-05-01), None
patent: 63 313721 (1988-12-01), None
patent: 1 479 049 (1989-05-01), None

Affiliated with

Also associated with

Rating

Pharmaceutical formulations of antineoplastic agents and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations of antineoplastic agents and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations of antineoplastic agents and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3603544